John Valliant
Founder at Centre For Probe Development & Commercialization
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Damian Lamb | M | 52 |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Lana Janes | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 3 years |
Eric Burak | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 12 years |
Christopher Kelly | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Bruno Paquin | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Jean-Claude Provost | M | 60 |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Gay Yuyitung | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Annick Van den Abbeele | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Karen Gulenchyn | F | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Peter Pattison | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 3 years |
Bettina Hamelin | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 3 years |
Sheila Singh | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 3 years |
David Huctwith | M | - |
McMaster University
| - |
Juliet Daniel | F | - |
McMaster University
| - |
Cara Ferreira | M | - | 4 years | |
Arjun Kumar | M | - |
McMaster University
| - |
Martin Kolb | M | - |
McMaster University
| - |
Constantinos Economou | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Anton Knezovic | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Barry Nicol | M | - |
McMaster University
| - |
Michael Ferencich | M | - |
McMaster University
| - |
Sonny Kohli | M | - |
McMaster University
| 14 years |
Fiona McNeill | F | - |
McMaster University
| - |
Jeanne Tan | F | - |
McMaster University
| - |
Chris Sinding | M | - |
McMaster University
| - |
Arlene Dosen | F | - |
McMaster University
| - |
Jerry Hurley | M | - |
McMaster University
| - |
Pamela Swett | F | - |
McMaster University
| - |
Karen Mossaman | F | - |
McMaster University
| - |
Marc Letendre | M | - |
McMaster University
| - |
Judith Shedden | F | - |
McMaster University
| - |
Khaled Hassanein | M | - |
McMaster University
| - |
Sara Bannerman | F | - |
McMaster University
| - |
Spencer Pope | M | - |
McMaster University
| - |
Judy West-Mays | F | - |
McMaster University
| - |
Sandeep Raha | M | - |
McMaster University
| - |
Dean Mountain | M | - |
McMaster University
| - |
Christina Bryce | F | - |
McMaster University
| - |
Stephanie Baschiera | F | - |
McMaster University
| - |
Michael Verbora | M | - |
McMaster University
| 6 years |
John Manley | M | 74 |
McMaster University
| - |
James Macpherson | M | - |
McMaster University
| - |
Emõke J. E. Szathmáry | M | 81 |
McMaster University
| - |
John Thornback | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Mary Maher | F | 63 |
McMaster University
| - |
Ronald Loucks | M | - |
McMaster University
| - |
John Bienenstock | M | 87 |
McMaster University
| - |
Robert G. Cooper | M | - |
McMaster University
| - |
James Paul | M | - |
McMaster University
| - |
James B. Mahony | M | - |
McMaster University
| - |
Grant B. Walsh | M | 75 |
McMaster University
| - |
Paul D. Campbell | M | 76 |
McMaster University
| - |
Richard Rossman | M | - |
McMaster University
| - |
Kevin P. D. Smith | M | 61 |
McMaster University
| - |
Rocco Taglioni | M | - |
McMaster University
| - |
Jim A. Wright | M | - |
McMaster University
| 14 years |
H. Barber | M | - |
McMaster University
| - |
Fraser Reeve Berrill | M | 75 |
McMaster University
| - |
Peter Horsewood | M | - |
McMaster University
| - |
Mark Larché | M | - |
McMaster University
| - |
Natalia K. Nikolova | M | - |
McMaster University
| 25 years |
John C. Luxat | M | - |
McMaster University
| - |
Lynton R. Wilson | M | 84 |
McMaster University
| - |
Joseph Gabriele | M | - |
McMaster University
| - |
Marion B. Lyver | M | - |
McMaster University
| - |
Jeffrey Weitz | M | - |
McMaster University
| - |
Michael T. Newhouse | M | - |
McMaster University
| - |
John Wallace | M | 67 |
McMaster University
| - |
Woo-Young Kim | M | - |
McMaster University
| 13 years |
Roger Couldrey | M | - |
McMaster University
| - |
Connie A. Stefankiewicz | F | - |
McMaster University
| - |
Maria D. Stahl | F | 53 | 4 years | |
Gary Kain | M | - |
McMaster University
| - |
Marc Kealey | M | - |
McMaster University
| - |
Paul Dixon Allison | M | - |
McMaster University
| - |
Yaser M. Haddara | M | - |
McMaster University
| - |
Emechete Onuoha | M | - |
McMaster University
| - |
S. R. Rafael Jose Faucher | M | - |
McMaster University
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mark Mihaljevic | M | - |
McMaster University
| 3 years |
Lisa Walter | M | - |
McMaster University
| 10 years |
Cindy Ward | F | - |
McMaster University
| 21 years |
Chau Khuong | M | 48 | 4 years | |
Michael Li | M | - |
McMaster University
| 7 years |
Aidan Giangregorio | M | - |
McMaster University
| 6 years |
Joe McCann | M | 47 |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 9 years |
Lynn Wick | F | - | 4 years | |
Joel Wagner | M | - |
McMaster University
| 6 years |
Chun Tai Yeung | M | 37 |
McMaster University
| 6 years |
Xianming Zhu | M | 41 |
McMaster University
| 2 years |
Wei Wang | M | 43 |
McMaster University
| 6 years |
James Orlando | M | - |
McMaster University
| 5 years |
T. Buckley | M | 48 |
McMaster University
| 6 years |
Paul Easterbrook | M | - |
McMaster University
| 6 years |
Rami Rahal | M | - |
McMaster University
| 4 years |
Ryan T. Goulding | M | - |
McMaster University
| 7 years |
Todd D'Amico | M | - |
McMaster University
| 6 years |
Kris Somers | M | - |
McMaster University
| 5 years |
Colum Bastable | M | 77 |
McMaster University
| - |
David Fidler | M | - |
McMaster University
| 2 years |
Jeff Pootoolal | M | - |
McMaster University
| 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Valliant
- Personal Network